{
    "Trade/Device Name(s)": [
        "BD Phoenix Automated Microbiology System - Tigecycline (0.25 - 16\u03bcg/mL)",
        "BD Phoenix Automated Microbiology System for use with the antimicrobial agent Tigecycline (0.25 - 16ug/mL) - Gram-negative ID/AST or AST only Phoenix Panels"
    ],
    "Submitter Information": "Becton, Dickinson and Company",
    "510(k) Number": "K132909",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "December 19, 2013",
    "Summary Letter Received Date": "December 20, 2013",
    "Submission Date": "February 5, 2014",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully automated short-term incubation cycle antimicrobial susceptibility system"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Tigecycline",
        "Citrobacter freundii",
        "Enterobacter cloacae",
        "Escherichia coli",
        "Klebsiella oxytoca",
        "Klebsiella pneumoniae",
        "Serratia marcescens",
        "Citrobacter koseri",
        "Enterobacter aerogenes"
    ],
    "Specimen Type(s)": [
        "Pure culture"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "BD Phoenix instrument",
        "BD Phoenix panels",
        "BD Phoenix software"
    ],
    "Method(s)/Technology(ies)": [
        "Automated susceptibility testing",
        "Broth based microdilution",
        "Redox indicator detection"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing",
        "Minimal inhibitory concentration determination",
        "Organism identification"
    ],
    "Submission Type(s)": [
        "System",
        "Instrument",
        "Panel",
        "Software",
        "Broth",
        "Indicator solution"
    ],
    "Document Summary": "FDA 510(k) summary for BD Phoenix Automated Microbiology System with Tigecycline for rapid organism identification and antimicrobial susceptibility testing by MIC.",
    "Indications for Use Summary": "Intended for in vitro quantitative determination of antimicrobial susceptibility by minimal inhibitory concentration (MIC) of Gram-negative aerobic and facultative anaerobic bacteria (Enterobacteriaceae and Non-Enterobacteriaceae) and Gram-positive bacteria (Staphylococcus, Enterococcus, Streptococcus) from pure culture using Tigecycline in Gram-negative ID/AST or AST only panels.",
    "fda_folder": "Microbiology"
}